Prof. Tobias Banaschewski, MD, PhD Phone:+49 (0)621 1703 4501 Fax:+49 (0)621 1703 4505 Email

 

Prof. Daniel Brandeis, sc. nat. Phone:+49 (0)621 1703 4922 Fax:+49 (0)621 1703 4505 Email

 

Prof. Ralf W. Dittmann, MD, PhD Phone:+49 (0)621 1703 4941 Fax:+49 (0)621 1703 4505 Email

Dr. Sarah Hohmann Phone:+49 (0)621 1703 4502 Fax:+49 (0)621 1703 4505 Email

 

Sarah Baumeister Phone:+49 (0)621 1703 4934 Fax:+49 (0)621 1703 4505 Email

 

Pascal Aggensteiner Phone:+49 (0)621 1703 4937 Fax:+49 (0)621 1703 4505 Email

 

Nathalie Holz Phone:+49 (0)621 1703 4904 Fax:+49 (0)621 1703 4505 Email

Institute presentation

The Central Institute of Mental Health (CIMH) in Mannheim, Germany is a globally recognized center of mental health and neuroscience. The CAP Department, headed by Prof. Tobias Banaschewski, MD, PhD specializes in top-level psychiatric treatment and research in neuropsychiatric disorders of childhood and adolescence. Research on efficacy and safety of medication treatment for psychiatric disorders in youths is a main research focus of the department. The Eli Lilly Endowed Chair for Paediatric Psychopharmacology at CAP focuses on clinical research with psychotropic compounds in children and adolescents. The CAP has 52 inpatient beds plus an outpatient facility with about 300 new child and adolescent CD patients per year. The clinical and research teams include a total of 18 child and adolescent psychiatrists, and 12 senior psychologists, 2 post-docs. The AP serves the spectrum of adult psychiatry (excluding addictions) with 175 inpatient and 32 outpatient beds. Research is focused on characterizing risk mechanisms across the lifespan for the development of new therapies, and integrated with clinical activities in a translational concept. CIMH has been involved in various multisite collaborations including international medication and neurofeedback trials, with principal investigator (PI) roles in several projects. We have solid experience in management (WP leadership, country coordinator responsibilities) and implementation of EU projects (PERS, STOP, ADDUCE, NEWMEDS, EU-GEI, OPTIMIZE, TACTICS and Aggressotype).